In the world of aesthetic medicine, a select group of professionals stands out for their precision, expertise, and d ...

A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

Bishop Auckland, County Durham local Colette Cooper woke up one morning to notice that one of her breasts had grown overnight ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...

In October 2024, Allergan Aesthetics scored a major FDA approval milestone when the company’s Botox Cosmetic injectable ...

Labor’s $15b manufacturing fund and superannuation giants have piled into a VC fund backing start-ups with promising drug and ...

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

The UKHSA has issued advice after more cases of the rare but serious condition botulism were linked to suspected fake ...

As the aesthetics industry continues to evolve, experienced and highly skilled injectors are pushing the boundaries of n ...